Cytokine quantification in the supernatant of mononuclear cell cultures and in blood serum from patients with Jorge Lobo's disease

Mycopathologia

Volumn 158, Issue 1, 2004, Pages 17-24

  Vilani Moreno, Fátima Regina ^a   Lauris, José Roberto Pereira ^b   Opromolla, Diltor Vladimir Araújo ^a  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cytokines; Jorge Lobo's disease; Lacazia loboi; peripheral blood mononuclear cells

Indexed keywords

CYTOKINE;

ARTICLE; BLOOD; DERMATOMYCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MALE; MIDDLE AGED; MONONUCLEAR CELL; NONPARAMETRIC TEST; RURAL POPULATION; TH2 CELL; ZYGOMYCETES;

CYTOKINES; DERMATOMYCOSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; RURAL POPULATION; STATISTICS, NONPARAMETRIC; TH2 CELLS; ZYGOMYCOTA;

FUNGI; LACAZIA LOBOI; ZYGOMYCETES;

EID: 4444344284     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MYCO.0000038433.76437.ec     Document Type: Article

References (37)

1. Lobo J. Um caso de blastomicose produzido por uma especie nova encontrada em Recife. Rev Med Pemamb 1931; 1: 763-775.
2. Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol 1999; 37: 2031-2033.
3. Opromolla DVA, Taborda PRO, Taborda VBA, Viana S, Furtado JF. Lobomicose: relato de 40 casos novos. An Bras Dermatol 1999; 74: 135-141.
4. Guimaães FN, Macedo DG. Contribuiçũo ao estudo das blastomicoses na Amazônia (blastomicose sul-americana). Hospital 1950; 38: 223-253.
5. Lacaz CS, Baruzzi RG, Rosa MCB. Doença de Jorge Lobo. São Paulo: USP-IPSIS 1986.
6. Silva D. Micose de Lobo. Rev Soc Bras Med Trop 1972; 6: 85-98.
7. Opromolla DVA, Belone AFF, Taborda PRO, Taborda VBA. Correlaç ãao clinicopatológica em 40 casos novos de lobomicose. An Bras Dermatol 2000; 75: 425-134.
8. Vilani-Moreno FR. Imunopatologia da doença de Jorge Lobo: composição celular do infiltrado inflamatòrio e quantiflcação de citocinas em sobrenadante de cultura de células mononucleares e soro sangüíneo [Tese]. Botucatu, São Paulo: UNESP, 2002; 159 pp.
9. Mendes-Giannini MJS, Camargo ME, Lacaz CS, Ferreira AW. Immunoenzymatic absorption test for serodiagnosis of paracoccidioidomycosis. J Clin Microbiol 1984; 20: 103-108.
10. Puccia R, Shenkman S, Gorin PAJ, Travassos LR. Exocellular components of Paracocckiioides brasiliensis. Identification of a specific antigen. Infect Immun 1985; 53: 199-206.
11. Vidal MSM, Palacios SA, Mélo NT, Lacaz CS. Reactivity of anti-gp43 antibodies from Paracoccidioides brasiliensis anti-serum with extracts from cutaneous lesions of Lobo's disease. Preliminary note. Rev Inst Med Trop São Paulo 1997; 39: 35-37.
12. Camargo ZP, Baruzzi RG, Maeda SM, Floriano MC. Antigenie relationship between Loboa loboi and Paracoccidioides brasiliensis as shown by serological methods. Med Mycol 1998; 36: 413-417.
13. Pecher SA, Fuchs J. Cellular immunity in Lobomycosis (Keloidal blastomycosis). Allergol Immunopathol 1988; 16: 413-415.
14. Calich VLG, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensis infection. Braz J Med Biol Res 1998; 31: 615-623.
15. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-279.
16. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z. Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun 1996; 64: 399-405.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21: 77-89.
18. Zar JH. Biostatistical analysis. 3nd ed. New Jersey: Prentice Hall, 1996.
19. Bava AJ, Mistchenko AS, Palacios MF, Fstevez ME, Tiraboschi NI, Sen L, et al. Lymphocyte subpopulations and cytokine production in paracoccidioidomycosis patients. Microbiol Immunol 1991; 35: 167-174.
20. Iwasso MTR, Soares AMVC, Santana J, Sartori A, Mendes RP, Marques SA, et al. Interleukin-2 in paracoccidioidomycosis. Rev Argent Micol 1992; 15: 59.
21. Bernard G, Romano CC, Carcere CR, Juvenale M, Mendes-Giannini MJ, Duarte AJ. Imbalance of IL-12, INF-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 2001; 13:248-252.
22. Rezkallah-Iwasso MT, Peraçali MTS, Mendes RP, Guastale HA, Barraviera B, Marques SA et al. Defective expression of interleukin-2 (IL-2) receptors in patients with paracoccidioidomycosis. In: Encuentro International sobre Paracoccidioidomycosis; 1989; Caracas. Caracas: Instituto Venezolano de Investigaciones Cientificas, 1989: 121.
23. Jardim RF, Andrade MEB, Aun WT, Mello JF, Criado PR. Cytokines. Rev Bras Alergia Imunopatol 1994; 17: 86-98.
24. Geller P, Geller M. Citocinas e imunorregulação. An Acad Nac Med 1997; 157: 97-102.
25. Varella PPV, Forte WCN. Citocinas: revisão. Rev Bras Alergia Imunopatol 2001; 24: 146-154.
26. Mackaness GB. The monocyte in cellular immunity. Semin Hematol 1970; 7: 172-184.
27. Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell. N Engl J Med 1980; 303: 622-626.
28. Nogueira MES, Vilani-Moreno FR, Marcos EVC, Silva EA. Avaliação imunológica de pacientes portadores da doença de Jorge Lobo. In: Anais do 36° Congresso da Sociedade Brasileira de Medicina Tropical; 2000; São Luis. São Luis, 2000: 274-275.
29. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153-205.
30. Ribeiro-Rodrigues R, Magalhães EFL, Tristão-Sá R, Pereira FEL, Dietze R. Fenotipagem de linfócitos circulantes, avaliação quantitativa das células produtoras de IL-4, IL-5, IL-6, IL-10 e INF-γ e fenotipagem das células do exudato inflamatório nas lesões, em um caso de blastornicose de Jorge Lobo. In: Anais do 38° Congresso da Sociedade Brasileira de Medicina Tropical; 2002; Foz do Iguaçu. Foz do Iguaçu, 2002: 198.
31. Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ et al. Mycobacterium leprae antigen-induced suppression of T cell proliferation in Vitro. J Immunol 1987; 138: 3028-3034.
32. Prasad HK, Mishra RS, Nath I. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type. J Exp Med 1987; 165: 239-245.
33. Sibley LD, Hunter SW, Brennan PJ, Krahenbhul JL. Mycobacterial lipoarabinomannan inhibits gamma interferon mediated activation of macrophages. Infect Immun 1988; 56: 1232-1236.
34. Vachula M, Holzer TJ, Andersen BR. Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae. J Immunol 1989; 142: 1696-1701.
35. Nakamura C, Fukutomi Y, Kashiwabara Y, Oomoto Y, Kojima M, Hayashi H et al. Dharmendra antigen but not integral M. leprae is an efficient inducer of immunostimulant cytokine production by human monocytes, and M. leprae lipids inhibit the cytokine production. Int J Lepr 1997; 65: 63-72.
36. Thorpe R, Wadha M, Bird CR, Mire-Sluis AR. Detection and measurement of cytokines. Blood Rev 1992; 6: 133-148.
37. Heney D, Whicher JT. Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement Ann Clin Biochem 1995; 32: 358-368.